As Connecticut's leader in treating hypertrophic cardiomyopathy (HCM) Yale New Haven Hospital Heart and Vascular Center offers everything from the latest imaging techniques and sophisticated genetic profiling of HCM, to advanced diagnostic testing, treatment options and clinical trials – all with an emphasis on compassion and communication.
Yale New Haven Hospital is recognized as a Hypertrophic Cardiomyopathy Center of Excellence by the Hypertrophic Cardiomyopathy Association and was the first hospital in Connecticut to achieve this status. Such centers are recognized for providing comprehensive diagnostic, treatment, education and research programs.
Hypertrophic cardiomyopathy is caused by a thickening of the heart muscle, blocking blood flow to the body. In some people, the thickened heart muscle can cause shortness of breath, chest pain or problems in the heart’s electrical system, causing abnormal heart rhythms.
Yale New Haven’s well-established HCM center provides specialized, expert physicians and staff specially trained to manage HCM. This multidisciplinary team has the experience necessary to provide seamless care to patients and their families, at every age and stage of this disease.
The HCM team includes specialists in:
Services include medical management, genetic counseling and family screening, advanced management of heart rhythm disorders, catheter-based procedures and when necessary, sophisticated surgical interventions. We also provide access to novel therapies, groundbreaking clinical trials, and offer monthly support group meetings.
The Hypertrophic Cardiomyopathy Program provides genetic counseling to every patient. Patients also have access to genetic screening, evaluation and treatment for all forms of inherited cardiovascular disease. A multidisciplinary team of physicians and scientists applies the latest cardiovascular genetic research results directly to patient care. We can evaluate an entire family for HCM, including a genetic profile and clinical evaluation. Our genetic counselors can also help patients with hypertrophic cardiomyopathy who plan to have children. We are committed to providing patients and their families with all information needed to make informed decisions about their health care.
